Combination of vemurafenib and cobimetinib in patients with advanced BRAFV600-mutated melanoma: a phase 1b study
Antoni Ribas(University of California, Los Angeles), René González(University of Colorado Cancer Center), Anna C. Pavlick(New York University), Omid Hamid(Angeles Clinic and Research Institute), Thomas F. Gajewski(University of Illinois Chicago), Adil Daud(University of California, San Francisco), Lawrence E. Flaherty(The Barbara Ann Karmanos Cancer Institute), Theodore F. Logan(Indiana University – Purdue University Indianapolis), Bartosz Chmielowski(University of California, Los Angeles), Karl D. Lewis(University of Colorado Cancer Center), Damien Kee(Peter MacCallum Cancer Centre), Peter D. Boasberg(Angeles Clinic and Research Institute), Ming Yin, Iris T. Chan, Luna Musib, Nicholas W. Choong, Igor Puzanov(Vanderbilt-Ingram Cancer Center), Grant A. McArthur(Peter MacCallum Cancer Centre)
Cited by 295